Literature DB >> 19566109

Potential vitamin-drug interactions in children: at a pediatric emergency department.

Ran D Goldman1, Sunita Vohra, Alex L Rogovik.   

Abstract

BACKGROUND: A significant increase in vitamin use has been observed in recent years and interactions between vitamins and medications have been reported.
OBJECTIVE: To determine the frequency and types of potential interactions between vitamins and medications in children arriving at a large tertiary, pediatric emergency department. We also compared family characteristics of children with potential interactions with those of children with no potential interactions, in order to determine children at a higher risk.
METHODS: A cross-sectional study in which a survey was conducted of parents/caregivers and/or patients aged 0-18 years registered at a large pediatric emergency department in Canada. A total of 1804 families underwent a face-to-face interview. The main outcome measure was the rate of potential vitamin interactions in the preceding 3 months.
RESULTS: A considerable number of patients (11% of our cohort) had potential vitamin-medication interactions in the preceding 3 months, which could theoretically result in adverse events, and over one-third of these children had more than one potential interaction. Patients with potential interactions and their parents were significantly older (p < 0.001 for the child and mother, p = 0.02 for the father), the children were much more likely to have a chronic illness (p < 0.001) and concurrently receive prescribed or over-the-counter medication (p < 0.001), and more children with potential interactions were completely immunized (p = 0.02). The child's sex, parental education, employment status, family income, and primary language spoken at home were not associated with potential interactions.
CONCLUSIONS: Taking into account the high rate of potential vitamin-drug interactions, especially among older children and patients with chronic illness, parents and healthcare providers need to balance the potential benefit of concurrent vitamin-medication use with its potential harms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566109     DOI: 10.2165/00148581-200911040-00004

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  40 in total

1.  Does metformin interfere with thiamine?

Authors:  Theodore A Alston
Journal:  Arch Intern Med       Date:  2003-04-28

2.  National Institutes of Health State-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention.

Authors: 
Journal:  Ann Intern Med       Date:  2006-07-31       Impact factor: 25.391

3.  The safety of mineral oil in the treatment of constipation--a lesson from prolonged overdose.

Authors:  Sharon Gal-Ezer; Ron Shaoul
Journal:  Clin Pediatr (Phila)       Date:  2006-11       Impact factor: 1.168

4.  Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid.

Authors:  R M Russell; B B Golner; S D Krasinski; J A Sadowski; P M Suter; C L Braun
Journal:  J Lab Clin Med       Date:  1988-10

5.  Interaction of ascorbic acid and warfarin.

Authors:  G Rosenthal
Journal:  JAMA       Date:  1971-03-08       Impact factor: 56.272

6.  Nicotinic acid deficiency induced by sodium valproate.

Authors:  M A Gillman; R Sandyk
Journal:  S Afr Med J       Date:  1984-06-23

7.  Dietary supplements in a national survey: Prevalence of use and reports of adverse events.

Authors:  Babgaleh B Timbo; Marianne P Ross; Patrick V McCarthy; Chung-Tung J Lin
Journal:  J Am Diet Assoc       Date:  2006-12

8.  Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine--a double-blind study in healthy subjects.

Authors:  H U Schulz; M Schürer; S Krupp; H G Dammann; J Timm; U Gessner
Journal:  Int J Clin Pharmacol Ther       Date:  2004-09       Impact factor: 1.366

Review 9.  How 'safe' are antioxidant vitamins?

Authors:  H S Garewal; A T Diplock
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

10.  Study of the role of vitamin B12 and folinic acid supplementation in preventing hematologic toxicity of zidovudine.

Authors:  M Falguera; J Perez-Mur; T Puig; G Cao
Journal:  Eur J Haematol       Date:  1995-08       Impact factor: 2.997

View more
  5 in total

1.  Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic.

Authors:  Petra Langerová; Michal Prokeš; Martin Konvalinka; Jana Fürstová; Karel Urbánek
Journal:  Eur J Pediatr       Date:  2013-01-19       Impact factor: 3.183

2.  Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies.

Authors:  Sunita Vohra; Kosta Cvijovic; Heather Boon; Brian C Foster; Walter Jaeger; Don LeGatt; George Cembrowski; Mano Murty; Ross T Tsuyuki; Joanne Barnes; Theresa L Charrois; John T Arnason; Candace Necyk; Mark Ware; Rhonda J Rosychuk
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

3.  Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality.

Authors:  Candace Necyk; Ross T Tsuyuki; Heather Boon; Brian C Foster; Don Legatt; George Cembrowski; Mano Murty; Joanne Barnes; Theresa L Charrois; John T Arnason; Mark A Ware; Rhonda J Rosychuk; Sunita Vohra
Journal:  BMJ Open       Date:  2014-03-28       Impact factor: 2.692

4.  Assessing Vitamins, Minerals and Supplements Marketed to Children in Canada.

Authors:  Charlene Elliott
Journal:  Int J Environ Res Public Health       Date:  2019-11-06       Impact factor: 3.390

5.  Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada.

Authors:  Pablo Santibanez; Katherine Gooch; Pamela Vo; Michelle Lorimer; Yurik Sandino
Journal:  BMC Health Serv Res       Date:  2012-12-08       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.